The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 334:1543-1544 June 6, 1996 Number 23
NextNext

Management of Gout

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Emmerson, B. T.
To the Editor: Emmerson's review of the management of gout (Feb. 15 issue)1 contains much useful information, but it also includes several arguable points. In their classic studies Gutman and Yü found that the excretion rate of urate in patients with gout was "almost invariably" within the normal range.2 Thus, it is wrong to suggest that "decreased urinary excretion of urate often contributes to hyperuricemia"1 and that measurements of urate clearance are clinically useful.

Their studies led Gutman and Yü and many other early workers to conclude that kidney changes were "the result and not the cause" of hyperuricemia. Subsequent . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.